Hanover (THG) Exec Grant: 48.815 RSUs Added; Vesting Tied to Prior Awards
Rhea-AI Filing Summary
Form 4 disclosure: Executive Vice President Jeffrey M. Farber of The Hanover Insurance Group (THG) reported an acquisition on 09/26/2025 of 48.815 shares of common stock in the form of restricted stock units (RSUs) at a $0 price. After the grant, he beneficially owns 45,991.495 shares. The filing states these RSUs were issued under the company’s 2022 Long-Term Incentive Plan as dividend equivalent accruals tied to earlier RSU awards and will vest on the third anniversary of the original grants.
This is an insider compensation-related grant rather than an open-market purchase or sale; the transaction was certified on 09/30/2025.
Positive
- Grant of 48.815 RSUs increases the executive’s alignment with shareholder interests through equity-based compensation
- Clear vesting schedule tied to original RSU grants (vesting on third anniversary) provides transparency on timing of potential ownership changes
Negative
- None.
Insights
TL;DR: Routine executive compensation grant; small incremental stake from dividend-equivalent RSUs, not an open-market trade.
The reported acquisition of 48.815 RSUs at $0 represents the mechanical conversion of dividend equivalents into additional restricted units tied to prior awards. This increases the reporting person’s beneficial position to 45,991.495 shares. Because vesting remains tied to the original grant schedule, the economic and governance implications are limited until vesting occurs. No cash consideration or change in control indicators are present.
TL;DR: Administrative equity grant consistent with compensation plan; standard disclosure under Section 16.
The form indicates the award is made under the 2022 LTIP as dividend equivalent accruals and vests on the third anniversary of the original RSUs. This is a typical practice to preserve economic parity for holders of restricted awards. The disclosure is complete regarding transaction type, amount, and vesting linkage; no material governance concerns or deviations from standard grant practices are evident from the filing.